Metoprolol Succinate
Product Images NDC 55648-735

6 FDA label images from Wockhardt Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 55648-735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Wockhardt Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Metosucertabs M Figure 01)

Structure (Metosucertabs M Figure 01)
Chemical structure of Metoprolol Succinate showing the molecular arrangement including the aromatic ring, hydroxy groups, ether linkages, amine group, and the succinate moiety.*
FDA Label Image

Figure (Metosucertabs M Figure 02)

Figure (Metosucertabs M Figure 02)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' comparing Metoprolol succinate extended-release tablets versus placebo across multiple subgroups for total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. The chart depicts relative risk and 95% confidence intervals for each subgroup listed on the vertical axis, with confidence intervals displayed as horizontal lines and effect estimates as squares.*
FDA Label Image

25 mg Label (Metosucertabs M Figure 03)

25 mg Label (Metosucertabs M Figure 03)
Label for Metoprolol Succinate Extended-Release Tablets, USP, 25 mg, manufactured by Wockhardt Limited. The label indicates the package contains 30 tablets. It includes dosage information, storage instructions, warnings, and distributor details for Wockhardt USA LLC. A barcode and NDC number 64679-734-01 are visible.*
FDA Label Image

50 mg Label (Metosucertabs M Figure 04)

50 mg Label (Metosucertabs M Figure 04)
Metoprolol Succinate Extended-Release Tablets, USP 50 mg, packaged in a container of 100 tablets. The label includes dosage information, warnings about storage and keeping out of reach of children, and manufacturer details from Wockhardt Limited, Mumbai, India. Distributed by Wockhardt USA LLC, Parsippany, NJ. The image also shows the product's NDC 64679-735-02 and a barcode.*
FDA Label Image

100 mg 12 Bottle Carton (Metosucertabs M Figure 05)

100 mg 12 Bottle Carton (Metosucertabs M Figure 05)
Packaging label for Metoprolol Succinate Extended-Release Tablets, USP, 100 mg by Wockhardt Limited. The label indicates Rx only, with 12 bottles inside and 30 tablets per bottle. The layout shows the front, back, and sides of the carton, featuring the product name, strength, and labeler information.*
FDA Label Image

200 mg Label (Metosucertabs M Figure 06)

200 mg Label (Metosucertabs M Figure 06)
Metoprolol Succinate Extended-Release Tablets, USP 200 mg by Wockhardt Limited displayed on a rectangular label. The label states the product contains 200 mg metoprolol succinate equivalent to 190 mg metoprolol tartrate per tablet. It is marked Rx only with a package size of 500 tablets. Additional information includes storage instructions, manufacturer and distributor details, and a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.